CN Stock MarketDetailed Quotes

300016 Beijing Beilu Pharmaceutical

Watchlist
  • 5.06
  • -0.17-3.25%
Market Closed May 13 15:00 CST
2.49BMarket Cap-34189P/E (TTM)

Beijing Beilu Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
10.35%207.51M
16.30%890.72M
16.60%649.82M
24.70%438.03M
2.23%188.04M
-10.93%765.88M
-18.14%557.31M
-34.38%351.26M
-17.18%183.93M
3.94%859.91M
Operating revenue
10.35%207.51M
16.30%890.72M
16.60%649.82M
24.70%438.03M
2.23%188.04M
-10.93%765.88M
-18.14%557.31M
-34.38%351.26M
-17.18%183.93M
3.94%859.91M
Other operating revenue
----
44.96%6.42M
----
-58.00%864.44K
----
44.69%4.43M
----
89.79%2.06M
----
690.75%3.06M
Total operating cost
5.58%191.5M
19.91%947.67M
24.16%675.05M
33.75%444.33M
21.20%181.38M
2.25%790.34M
-4.24%543.7M
-20.39%332.2M
-13.96%149.65M
13.68%772.98M
Operating cost
-6.45%92.11M
38.15%472.01M
44.72%331.88M
55.04%221.05M
34.66%98.45M
5.31%341.66M
-4.61%229.32M
-27.26%142.58M
-11.95%73.11M
17.35%324.44M
Operating tax surcharges
49.61%2.69M
-10.15%10.29M
10.22%8.51M
7.29%5.68M
-25.30%1.8M
11.04%11.45M
1.78%7.72M
-18.04%5.29M
-6.59%2.41M
-11.24%10.31M
Operating expense
52.54%52.05M
3.08%217.05M
4.44%154.42M
16.57%102.2M
-12.18%34.12M
-26.03%210.56M
-30.29%147.86M
-37.22%87.67M
-21.47%38.85M
6.45%284.65M
Administration expense
1.25%18.05M
-4.61%81.74M
-15.07%55.51M
-5.26%36.71M
-6.55%17.82M
8.54%85.69M
19.13%65.36M
3.86%38.75M
1.52%19.07M
0.65%78.95M
Financial expense
4.78%12.72M
5.43%44.26M
32.98%38.38M
38.91%25M
38.93%12.14M
53.22%41.98M
40.07%28.86M
32.58%18M
48.76%8.74M
580.61%27.4M
-Interest expense (Financial expense)
10.00%13.76M
11.53%53.14M
12.81%39.66M
11.11%25.38M
13.07%12.51M
7.82%47.64M
8.47%35.16M
5.55%22.84M
3.77%11.06M
812.67%44.19M
-Interest Income (Financial expense)
35.24%-1.68M
-39.34%-11.82M
-11.01%-6.68M
-7.43%-4.32M
-37.90%-2.6M
35.71%-8.48M
39.39%-6.02M
37.36%-4.02M
32.18%-1.88M
-20.58%-13.2M
Research and development
-18.50%13.89M
23.55%122.33M
33.70%86.35M
34.51%53.7M
128.07%17.04M
109.64%99.01M
100.45%64.58M
64.21%39.92M
-47.36%7.47M
-8.69%47.23M
Credit Impairment Loss
143.39%879.63K
-598.64%-3.83M
-226.30%-1.76M
-202.20%-1.71M
-64.45%361.41K
-42.19%768.89K
96.06%1.39M
140.56%1.67M
307.61%1.02M
483.59%1.33M
Asset Impairment Loss
-34.34%-834.08K
-89.72%-45.18M
-25.60%-3.75M
-215.35%-3.43M
66.55%-620.86K
-572.32%-23.81M
-108.25%-2.99M
-0.34%-1.09M
-78.33%-1.86M
12.18%-3.54M
Other net revenue
-103.84%-139.04K
-489.15%-43.49M
-45.72%15.49M
-55.68%8.41M
-36.81%3.62M
-72.23%11.18M
1.60%28.54M
105.49%18.98M
27.59%5.74M
12.58%40.25M
Fair value change income
-229.90%-3.68M
-153.19%-13.96M
-56.54%9.19M
-49.60%6.54M
-43.54%2.84M
88.78%26.24M
124.23%21.15M
124.64%12.98M
8.68%5.02M
-28.39%13.9M
Invest income
530.08%849.8K
205.20%5.99M
264.67%4.51M
192.70%3.63M
-150.05%-197.59K
-143.39%-5.7M
-160.91%-2.74M
-175.95%-3.91M
93.37%394.8K
131.81%13.13M
-Including: Investment income associates
53.16%-371.13K
117.23%1.95M
185.91%1.7M
152.80%1.13M
-10,627.56%-792.28K
-585.00%-11.35M
-240.81%-1.98M
-245.41%-2.13M
-102.77%-7.39K
78.36%2.34M
Asset deal income
--1.82K
801.04%894.31K
772.62%866.11K
--866.11K
----
-21.32%99.25K
-21.32%99.25K
----
----
--126.15K
Other revenue
112.50%2.65M
-7.27%12.59M
-44.70%6.43M
-73.03%2.52M
7.54%1.25M
-11.30%13.58M
-21.23%11.62M
165.57%9.33M
-3.50%1.16M
1.64%15.31M
Operating profit
54.28%15.86M
-656.17%-100.44M
-123.10%-9.74M
-94.44%2.11M
-74.30%10.28M
-110.44%-13.28M
-70.14%42.15M
-70.10%38.04M
-23.97%40.01M
-30.55%127.17M
Add:Non operating Income
92.12%49.32K
386.71%1.77M
3,896.51%1.52M
3,858.83%1.5M
25,570.58%25.67K
31.74%363.23K
-85.89%37.99K
-78.10%37.99K
-93.34%100
285.32%275.71K
Less:Non operating expense
-88.33%3.71K
34.81%2.48M
-41.90%811.19K
-29.80%543.44K
-94.07%31.83K
-63.84%1.84M
-67.83%1.4M
-77.36%774.19K
60.71%536.46K
-45.58%5.09M
Total profit
54.82%15.91M
-585.25%-101.15M
-122.14%-9.03M
-91.76%3.07M
-73.97%10.28M
-112.06%-14.76M
-70.24%40.79M
-69.91%37.3M
-24.51%39.48M
-29.61%122.36M
Less:Income tax cost
4,586.93%4.29M
-75.80%-17.95M
-253.02%-4.81M
-164.74%-1.88M
-98.05%91.47K
-184.67%-10.21M
-109.09%-1.36M
-80.19%2.91M
-32.56%4.7M
-39.20%12.06M
Net profit
14.11%11.62M
FPtoL-83.2M
SL-4.21M
-85.59%4.96M
-70.72%10.18M
SL-4.55M
-65.47%42.15M
-68.53%34.4M
-23.27%34.78M
-28.38%110.29M
Net profit from continuing operation
14.11%11.62M
-1,728.99%-83.2M
-110.00%-4.21M
-85.59%4.96M
-70.72%10.18M
-104.12%-4.55M
-65.47%42.15M
-68.53%34.4M
-23.27%34.78M
-28.38%110.29M
Less:Minority Profit
103.97%95.08K
27.72%-11.44M
52.87%-6.16M
17.80%-4.65M
46.69%-2.39M
-4.02%-15.83M
-70.25%-13.06M
21.35%-5.65M
12.47%-4.49M
26.49%-15.22M
Net profit of parent company owners
-8.35%11.53M
-735.92%-71.76M
-96.48%1.94M
-76.02%9.6M
-67.97%12.58M
-91.01%11.28M
-57.44%55.21M
-65.62%40.05M
-22.18%39.26M
-28.15%125.51M
Earning per share
Basic earning per share
-8.20%0.0235
-850.00%-0.15
-96.44%0.004
-75.00%0.02
-68.00%0.0256
-92.31%0.02
-57.60%0.1125
-66.67%0.08
-22.48%0.08
-27.78%0.26
Diluted earning per share
-0.95%0.0415
-187.50%-0.07
-64.17%0.0535
-54.55%0.05
-49.58%0.0419
-71.43%0.08
-47.85%0.1493
-56.00%0.11
-27.36%0.0831
-22.22%0.28
Other composite income
-1,097.95%-714.27K
Other composite income of parent company owners
----
----
----
----
----
----
----
----
----
-1,097.95%-714.27K
Total composite income
14.11%11.62M
-1,728.99%-83.2M
-110.00%-4.21M
-85.59%4.96M
-70.72%10.18M
-104.15%-4.55M
-65.45%42.15M
-68.52%34.4M
-23.24%34.78M
-28.82%109.58M
Total composite income of parent company owners
-8.35%11.53M
-735.92%-71.76M
-96.48%1.94M
-76.02%9.6M
-67.97%12.58M
-90.96%11.28M
-57.42%55.21M
-65.61%40.05M
-22.14%39.26M
-28.54%124.8M
Total composite income of minority owners
103.97%95.08K
27.72%-11.44M
52.87%-6.16M
17.80%-4.65M
46.69%-2.39M
-4.02%-15.83M
-70.25%-13.06M
21.35%-5.65M
12.47%-4.49M
26.49%-15.22M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 10.35%207.51M16.30%890.72M16.60%649.82M24.70%438.03M2.23%188.04M-10.93%765.88M-18.14%557.31M-34.38%351.26M-17.18%183.93M3.94%859.91M
Operating revenue 10.35%207.51M16.30%890.72M16.60%649.82M24.70%438.03M2.23%188.04M-10.93%765.88M-18.14%557.31M-34.38%351.26M-17.18%183.93M3.94%859.91M
Other operating revenue ----44.96%6.42M-----58.00%864.44K----44.69%4.43M----89.79%2.06M----690.75%3.06M
Total operating cost 5.58%191.5M19.91%947.67M24.16%675.05M33.75%444.33M21.20%181.38M2.25%790.34M-4.24%543.7M-20.39%332.2M-13.96%149.65M13.68%772.98M
Operating cost -6.45%92.11M38.15%472.01M44.72%331.88M55.04%221.05M34.66%98.45M5.31%341.66M-4.61%229.32M-27.26%142.58M-11.95%73.11M17.35%324.44M
Operating tax surcharges 49.61%2.69M-10.15%10.29M10.22%8.51M7.29%5.68M-25.30%1.8M11.04%11.45M1.78%7.72M-18.04%5.29M-6.59%2.41M-11.24%10.31M
Operating expense 52.54%52.05M3.08%217.05M4.44%154.42M16.57%102.2M-12.18%34.12M-26.03%210.56M-30.29%147.86M-37.22%87.67M-21.47%38.85M6.45%284.65M
Administration expense 1.25%18.05M-4.61%81.74M-15.07%55.51M-5.26%36.71M-6.55%17.82M8.54%85.69M19.13%65.36M3.86%38.75M1.52%19.07M0.65%78.95M
Financial expense 4.78%12.72M5.43%44.26M32.98%38.38M38.91%25M38.93%12.14M53.22%41.98M40.07%28.86M32.58%18M48.76%8.74M580.61%27.4M
-Interest expense (Financial expense) 10.00%13.76M11.53%53.14M12.81%39.66M11.11%25.38M13.07%12.51M7.82%47.64M8.47%35.16M5.55%22.84M3.77%11.06M812.67%44.19M
-Interest Income (Financial expense) 35.24%-1.68M-39.34%-11.82M-11.01%-6.68M-7.43%-4.32M-37.90%-2.6M35.71%-8.48M39.39%-6.02M37.36%-4.02M32.18%-1.88M-20.58%-13.2M
Research and development -18.50%13.89M23.55%122.33M33.70%86.35M34.51%53.7M128.07%17.04M109.64%99.01M100.45%64.58M64.21%39.92M-47.36%7.47M-8.69%47.23M
Credit Impairment Loss 143.39%879.63K-598.64%-3.83M-226.30%-1.76M-202.20%-1.71M-64.45%361.41K-42.19%768.89K96.06%1.39M140.56%1.67M307.61%1.02M483.59%1.33M
Asset Impairment Loss -34.34%-834.08K-89.72%-45.18M-25.60%-3.75M-215.35%-3.43M66.55%-620.86K-572.32%-23.81M-108.25%-2.99M-0.34%-1.09M-78.33%-1.86M12.18%-3.54M
Other net revenue -103.84%-139.04K-489.15%-43.49M-45.72%15.49M-55.68%8.41M-36.81%3.62M-72.23%11.18M1.60%28.54M105.49%18.98M27.59%5.74M12.58%40.25M
Fair value change income -229.90%-3.68M-153.19%-13.96M-56.54%9.19M-49.60%6.54M-43.54%2.84M88.78%26.24M124.23%21.15M124.64%12.98M8.68%5.02M-28.39%13.9M
Invest income 530.08%849.8K205.20%5.99M264.67%4.51M192.70%3.63M-150.05%-197.59K-143.39%-5.7M-160.91%-2.74M-175.95%-3.91M93.37%394.8K131.81%13.13M
-Including: Investment income associates 53.16%-371.13K117.23%1.95M185.91%1.7M152.80%1.13M-10,627.56%-792.28K-585.00%-11.35M-240.81%-1.98M-245.41%-2.13M-102.77%-7.39K78.36%2.34M
Asset deal income --1.82K801.04%894.31K772.62%866.11K--866.11K-----21.32%99.25K-21.32%99.25K----------126.15K
Other revenue 112.50%2.65M-7.27%12.59M-44.70%6.43M-73.03%2.52M7.54%1.25M-11.30%13.58M-21.23%11.62M165.57%9.33M-3.50%1.16M1.64%15.31M
Operating profit 54.28%15.86M-656.17%-100.44M-123.10%-9.74M-94.44%2.11M-74.30%10.28M-110.44%-13.28M-70.14%42.15M-70.10%38.04M-23.97%40.01M-30.55%127.17M
Add:Non operating Income 92.12%49.32K386.71%1.77M3,896.51%1.52M3,858.83%1.5M25,570.58%25.67K31.74%363.23K-85.89%37.99K-78.10%37.99K-93.34%100285.32%275.71K
Less:Non operating expense -88.33%3.71K34.81%2.48M-41.90%811.19K-29.80%543.44K-94.07%31.83K-63.84%1.84M-67.83%1.4M-77.36%774.19K60.71%536.46K-45.58%5.09M
Total profit 54.82%15.91M-585.25%-101.15M-122.14%-9.03M-91.76%3.07M-73.97%10.28M-112.06%-14.76M-70.24%40.79M-69.91%37.3M-24.51%39.48M-29.61%122.36M
Less:Income tax cost 4,586.93%4.29M-75.80%-17.95M-253.02%-4.81M-164.74%-1.88M-98.05%91.47K-184.67%-10.21M-109.09%-1.36M-80.19%2.91M-32.56%4.7M-39.20%12.06M
Net profit 14.11%11.62MFPtoL-83.2MSL-4.21M-85.59%4.96M-70.72%10.18MSL-4.55M-65.47%42.15M-68.53%34.4M-23.27%34.78M-28.38%110.29M
Net profit from continuing operation 14.11%11.62M-1,728.99%-83.2M-110.00%-4.21M-85.59%4.96M-70.72%10.18M-104.12%-4.55M-65.47%42.15M-68.53%34.4M-23.27%34.78M-28.38%110.29M
Less:Minority Profit 103.97%95.08K27.72%-11.44M52.87%-6.16M17.80%-4.65M46.69%-2.39M-4.02%-15.83M-70.25%-13.06M21.35%-5.65M12.47%-4.49M26.49%-15.22M
Net profit of parent company owners -8.35%11.53M-735.92%-71.76M-96.48%1.94M-76.02%9.6M-67.97%12.58M-91.01%11.28M-57.44%55.21M-65.62%40.05M-22.18%39.26M-28.15%125.51M
Earning per share
Basic earning per share -8.20%0.0235-850.00%-0.15-96.44%0.004-75.00%0.02-68.00%0.0256-92.31%0.02-57.60%0.1125-66.67%0.08-22.48%0.08-27.78%0.26
Diluted earning per share -0.95%0.0415-187.50%-0.07-64.17%0.0535-54.55%0.05-49.58%0.0419-71.43%0.08-47.85%0.1493-56.00%0.11-27.36%0.0831-22.22%0.28
Other composite income -1,097.95%-714.27K
Other composite income of parent company owners -------------------------------------1,097.95%-714.27K
Total composite income 14.11%11.62M-1,728.99%-83.2M-110.00%-4.21M-85.59%4.96M-70.72%10.18M-104.15%-4.55M-65.45%42.15M-68.52%34.4M-23.24%34.78M-28.82%109.58M
Total composite income of parent company owners -8.35%11.53M-735.92%-71.76M-96.48%1.94M-76.02%9.6M-67.97%12.58M-90.96%11.28M-57.42%55.21M-65.61%40.05M-22.14%39.26M-28.54%124.8M
Total composite income of minority owners 103.97%95.08K27.72%-11.44M52.87%-6.16M17.80%-4.65M46.69%-2.39M-4.02%-15.83M-70.25%-13.06M21.35%-5.65M12.47%-4.49M26.49%-15.22M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Grant Tung Certified Public Accountants (Special General Partnership)------Grant Tung Certified Public Accountants (Special General Partnership)------Grant Tung Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg